JP2024531682A5 - - Google Patents

Info

Publication number
JP2024531682A5
JP2024531682A5 JP2024515828A JP2024515828A JP2024531682A5 JP 2024531682 A5 JP2024531682 A5 JP 2024531682A5 JP 2024515828 A JP2024515828 A JP 2024515828A JP 2024515828 A JP2024515828 A JP 2024515828A JP 2024531682 A5 JP2024531682 A5 JP 2024531682A5
Authority
JP
Japan
Prior art keywords
positive
cell population
inhibitor
committed
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024531682A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076328 external-priority patent/WO2023039588A1/en
Publication of JP2024531682A publication Critical patent/JP2024531682A/ja
Publication of JP2024531682A5 publication Critical patent/JP2024531682A5/ja
Pending legal-status Critical Current

Links

JP2024515828A 2021-09-13 2022-09-13 コミットされた心臓始原細胞の製造方法 Pending JP2024531682A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163243606P 2021-09-13 2021-09-13
US63/243,606 2021-09-13
PCT/US2022/076328 WO2023039588A1 (en) 2021-09-13 2022-09-13 Methods for the production of committed cardiac progenitor cells

Publications (2)

Publication Number Publication Date
JP2024531682A JP2024531682A (ja) 2024-08-29
JP2024531682A5 true JP2024531682A5 (https=) 2025-09-12

Family

ID=83508810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515828A Pending JP2024531682A (ja) 2021-09-13 2022-09-13 コミットされた心臓始原細胞の製造方法

Country Status (8)

Country Link
US (1) US20230078230A1 (https=)
EP (1) EP4402249A1 (https=)
JP (1) JP2024531682A (https=)
KR (1) KR20240056604A (https=)
CN (1) CN118159646A (https=)
AU (1) AU2022343749A1 (https=)
CA (1) CA3231501A1 (https=)
WO (1) WO2023039588A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025117472A1 (en) * 2023-11-30 2025-06-05 Immorta Bio, Inc. Treatment of heart failure using pluripotent stem cell derived cardiomyocytes and derivatives thereof

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197915B (en) 1986-11-19 1990-11-14 Rolls Royce Plc Improvements in or relating to fluid bearings
US6416998B1 (en) 1992-09-02 2002-07-09 Baylor College Of Medicine Plasmid encoding a modified steroid hormone
US5874301A (en) 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5763270A (en) 1995-06-07 1998-06-09 Genemedicine, Inc. Plasmid for delivery of nucleic acids to cells and methods of use
CA2277278A1 (en) 1997-01-10 1998-07-16 Life Technologies, Inc. Embryonic stem cell serum replacement
US6099832A (en) 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
US6280718B1 (en) 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
IL155728A0 (en) 2000-11-22 2003-11-23 Geron Corp Tolerizing allografts of pluripotent stem cells
PE20020958A1 (es) 2001-03-23 2002-11-14 Bayer Corp Inhibidores de la rho-quinasa
UY27224A1 (es) 2001-03-23 2002-10-31 Bayer Corp Inhibidores de la rho-quinasa
US20030211603A1 (en) 2001-08-14 2003-11-13 Earp David J. Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
IL162130A0 (en) 2001-12-07 2005-11-20 Robarts Res Inst Hematopoietic cells from human embryonic stem cells
JP4505228B2 (ja) 2002-01-10 2010-07-21 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト Ｒｈｏ−キナーゼ阻害剤
EP1470121B1 (en) 2002-01-23 2012-07-11 Bayer HealthCare LLC Pyrimidine derivatives as rho-kinase inhibitors
MXPA04007196A (es) 2002-01-23 2005-06-08 Bayer Pharmaceuticals Corp Inhibidores de rho-quinasa.
AU2003263653A1 (en) 2002-09-27 2004-04-19 Daewoong Co., Ltd. A vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus
ES2273047T3 (es) 2002-10-28 2007-05-01 Bayer Healthcare Ag Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa.
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
WO2005123902A1 (ja) 2004-06-18 2005-12-29 Riken 無血清浮遊培養による胚性幹細胞の神経分化誘導法
AU2005282414C1 (en) 2004-09-08 2011-04-07 Wisconsin Alumni Research Foundation Culturing human embryonic stem cells
EP3147296A1 (en) 2005-11-14 2017-03-29 Merial, Inc. Gene therapy for renal failure
US20070116680A1 (en) 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8129187B2 (en) 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
JP5813321B2 (ja) 2007-03-23 2015-11-17 ウィスコンシン アラムニ リサーチ ファンデーション 体細胞の再プログラム化
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
EP3279314A1 (en) 2008-06-04 2018-02-07 Cellular Dynamics International, Inc. Methods for the production of ips cells using non-viral approach
AU2009274517B2 (en) * 2008-07-25 2015-03-26 The University Of Georgia Research Foundation, Inc. Compositions for Mesoderm derived ISL1+ Multipotent cells (IMPs), epicardial progenitor cells (EPCs) and multipotent CXCR4+CD56+ cells (C56Cs) and methods of use
CA2734128A1 (en) 2008-08-12 2010-02-18 Cellular Dynamics International, Inc. Methods for the production of ips cells
DK2356221T3 (en) 2008-10-24 2019-02-18 Wisconsin Alumni Res Found Pluripotent stem cells obtained by non-viral reprogramming
WO2010141801A2 (en) 2009-06-05 2010-12-09 Cellular Dynamics International, Inc. Reprogramming t cells and hematophietic cells
CA2770412C (en) 2009-08-07 2018-09-11 Kyoto University Method of efficiently establishing induced pluripotent stem cells
JP5902092B2 (ja) 2009-10-19 2016-04-13 セルラー ダイナミクス インターナショナル， インコーポレイテッド 心筋細胞の生成
WO2011056971A2 (en) 2009-11-04 2011-05-12 Cellular Dynamics International, Inc. Episomal reprogramming with chemicals
US9005967B2 (en) 2010-01-22 2015-04-14 Kyoto University Myc variants improve induced pluripotent stem cell generation efficiency
WO2011159684A2 (en) 2010-06-15 2011-12-22 Cellular Dynamics International, Inc. Generation of induced pluripotent stem cells from small volumes of peripheral blood
US9884076B2 (en) * 2012-06-05 2018-02-06 Capricor, Inc. Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
US20150337266A1 (en) * 2012-12-28 2015-11-26 Kyoto University Method for producing induced pluripotent stem cells, cardiomyocytes or precursor cells thereof
MA40589A (fr) * 2014-08-22 2017-06-28 Procella Therapeutics Ab Utilisation de jagged 1/frizzled 4 à titre de marqueurs de surface cellulaire pour isoler des cellules progénitrices ventriculaires cardiaques humaines
US9765299B2 (en) * 2014-09-10 2017-09-19 Wisconsin Alumni Research Foundation Chemically defined albumin-free conditions for cardiomyocyte differentiation of human pluripotent stem cells
CA3109078A1 (en) * 2018-07-17 2020-01-23 The Regents Of The University Of California Cells differentiated from immunoengineered pluripotent cells

Similar Documents

Publication Publication Date Title
Vats et al. Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment
KR102278652B1 (ko) 섬 세포 재세포화를 위한 관류 탈세포화된 간의 용도
Levenberg Engineering blood vessels from stem cells: recent advances and applications
Montserrat et al. Regenerative strategies for kidney engineering
US20250295701A1 (en) Kit for Induction of Continuous Expansion of Hepatoblast Organoids and/or Hepatocyte Organoids Under 3D Suspension Conditions and Use Thereof
JPWO2019107535A1 (ja) 多能性幹細胞からの立体臓器の構築
Pagliari et al. A multistep procedure to prepare pre-vascularized cardiac tissue constructs using adult stem sells, dynamic cell cultures, and porous scaffolds
CN113337458A (zh) 一种提高多能干细胞定向诱导心肌细胞产量及纯度的方法
CN113699098A (zh) 三维血管化心肌组织及其制备方法和应用
Hanjaya‐Putra et al. Vascular engineering using human embryonic stem cells
CN111909887A (zh) 获得肝脏细胞的方法和组合物
US9428735B2 (en) Smooth muscle-like cells (SMLCs) dervided from human pluripotent stem cells
CN105647860A (zh) 临床治疗级人胎盘底蜕膜来源的间充质干细胞(PDB-MSCs)无血清体外提取制备方法
JP7094567B2 (ja) 神経堤細胞および交感神経細胞の製造方法
KR20230143136A (ko) 자가 조직화된 인간 심장 오가노이드
CN120158421A (zh) 一种共分化的血管化肝类器官及其构建方法
JP2024531682A5 (https=)
Luo et al. The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: recent advances and current challenges
JP2023536421A (ja) 多能性幹細胞由来細胞の大規模製造のための閉鎖型製造プロセス
CN117384824A (zh) 基于iPSC的人血管化肺类器官及其构建方法
WO2023106122A1 (ja) 間葉系譜への分化に特化した神経堤細胞の製造方法
CN119570719A (zh) 一种心脏类器官及其体外制备方法
WO2020067439A1 (ja) 心筋細胞のシート化方法
CN115786245A (zh) 人仿生肺脏类器官构建方法
CN117946960B (zh) 一种血管化的类器官及其制备方法